• Je něco špatně v tomto záznamu ?

Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses

H. Mostafaei, K. Mori, S. Hajebrahimi, M. Abufaraj, PI. Karakiewicz, SF. Shariat

. 2021 ; 128 (1) : 3-11. [pub] 20210109

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004117

OBJECTIVES: To present an overall picture of the evidence regarding the association of erectile dysfunction (ED) with cardiovascular disease (CVD). METHODS: Systematic reviews and meta-analyses that studied the association of ED with any CVD were included in this umbrella review. We did not restrict the population to a particular group or age. PubMed, Embase, the Joanna Briggs Institute (JBI) Database of Systematic Reviews and Implementation Reports, the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, and the PROSPERO register were searched to find relevant systematic reviews, with or without meta-analyses, from inception to April 2020. The JBI Checklist for Systematic Reviews and Research Syntheses was used for the critical appraisal. Only studies with acceptable quality were included. Two independent reviewers extracted the data using the JBI data extraction tool for qualitative and quantitative data extraction. RESULTS: The summary estimate showed a higher risk of CVD (relative risk [RR] 1.45, 95% confidence interval [CI] 1.36-1.54; P < 0.001), coronary heart disease (RR 1.50, 95% CI 1.37-1.64; P < 0.001), cardiovascular-related mortality (RR 1.50, 95% CI 1.37-1.64; P < 0.001), all-cause mortality (RR 1.25, 95% CI 1.18-1.32; P < 0.001), myocardial infarction (RR 1.55, 95% CI 1.33-1.80; P < 0.001) and stroke (RR 1.36, 95% CI 1.26-1.46; P < 0.001) in patients with ED than in other patients. CONCLUSIONS: Our results confirm that ED is an independent predictor of CVD and their outcomes. ED and CVD are two presentations of the same physiological phenomenon. ED normally precedes symptomatic CVD, providing a window of opportunity for healthcare practitioners to screen and detect high-risk patients early to prevent avoidable morbidity and mortality.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004117
003      
CZ-PrNML
005      
20220127145520.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bju.15313 $2 doi
035    __
$a (PubMed)33260254
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Mostafaei, Hadi $u Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria $u Research Centre for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
245    10
$a Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses / $c H. Mostafaei, K. Mori, S. Hajebrahimi, M. Abufaraj, PI. Karakiewicz, SF. Shariat
520    9_
$a OBJECTIVES: To present an overall picture of the evidence regarding the association of erectile dysfunction (ED) with cardiovascular disease (CVD). METHODS: Systematic reviews and meta-analyses that studied the association of ED with any CVD were included in this umbrella review. We did not restrict the population to a particular group or age. PubMed, Embase, the Joanna Briggs Institute (JBI) Database of Systematic Reviews and Implementation Reports, the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, and the PROSPERO register were searched to find relevant systematic reviews, with or without meta-analyses, from inception to April 2020. The JBI Checklist for Systematic Reviews and Research Syntheses was used for the critical appraisal. Only studies with acceptable quality were included. Two independent reviewers extracted the data using the JBI data extraction tool for qualitative and quantitative data extraction. RESULTS: The summary estimate showed a higher risk of CVD (relative risk [RR] 1.45, 95% confidence interval [CI] 1.36-1.54; P < 0.001), coronary heart disease (RR 1.50, 95% CI 1.37-1.64; P < 0.001), cardiovascular-related mortality (RR 1.50, 95% CI 1.37-1.64; P < 0.001), all-cause mortality (RR 1.25, 95% CI 1.18-1.32; P < 0.001), myocardial infarction (RR 1.55, 95% CI 1.33-1.80; P < 0.001) and stroke (RR 1.36, 95% CI 1.26-1.46; P < 0.001) in patients with ED than in other patients. CONCLUSIONS: Our results confirm that ED is an independent predictor of CVD and their outcomes. ED and CVD are two presentations of the same physiological phenomenon. ED normally precedes symptomatic CVD, providing a window of opportunity for healthcare practitioners to screen and detect high-risk patients early to prevent avoidable morbidity and mortality.
650    _2
$a kardiovaskulární nemoci $x komplikace $7 D002318
650    _2
$a erektilní dysfunkce $x komplikace $7 D007172
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a metaanalýza jako téma $7 D015201
650    12
$a systematický přehled jako téma $7 D000078202
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mori, Keiichiro $u Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria $u Department of Urology, Jikei University School of Medicine, Tokyo, Japan
700    1_
$a Hajebrahimi, Sakineh $u Research Centre for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
700    1_
$a Abufaraj, Mohammad $u Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria $u Division of Urology, Department of Special Surgery, Jordan University Hospital, University of Jordan, Amman, Jordan
700    1_
$a Karakiewicz, Pierre I $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria $u Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX, USA $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Urology, University of Jordan, Amman, Jordan $u European Association of Urology Research Foundation, Arnhem, The Netherlands
773    0_
$w MED00011371 $t BJU international $x 1464-410X $g Roč. 128, č. 1 (2021), s. 3-11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33260254 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145516 $b ABA008
999    __
$a ok $b bmc $g 1751547 $s 1155266
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 128 $c 1 $d 3-11 $e 20210109 $i 1464-410X $m BJU international $n BJU Int $x MED00011371
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace